Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
CARY, N.C., May 30, 2024 /PRNewswire/ --Veloxis, Inc. (Veloxis), a fully integrated specialty pharmaceutical company, is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC). VEL-101 (also known …